Healthtech Startups

F2G develops medicines to treat serious fungal diseases where existing therapies have failed or are ineffective. The company operates an early access program to provide investigational therapies to qualified patients with life-threatening fungal infections who are ineligible for clinical trials or lack suitable alternative treatment options.

7 investors

Finni matches families and children with autism spectrum disorder with ABA (Applied Behavior Analysis) therapy providers in their local area. The platform serves as a marketplace connecting patients with licensed care providers and works with insurance to make therapy accessible.

7 investors

Fitbit designs and develops wearable fitness tracking devices and associated software that monitor health metrics and physical activity.

7 investors

Flo is a women's health app offering personalized cycle tracking, fertility guidance, pregnancy support, and health education backed by a medical team. The app serves women and people with periods globally with science-based insights on hormonal health from first period to perimenopause.

7 investors

Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells. A spin-out of the Centre for Probe Development and Commercialization, it focuses on radiopharmaceuticals for cancer treatment.

7 investors

Future provides personalized coaching services powered by technology to help people build strength, improve movement, and support long-term health outcomes. The company serves individuals seeking accessible, personalized fitness and wellness guidance.

7 investors

Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.

7 investors

Glidian offers an all-payor prior authorization platform that lets healthcare providers submit and track insurance authorizations through direct payor integrations, supported by a team of prior authorization specialists. The tool serves provider organizations across all US states, aiming to reduce denials and increase submission throughput.

7 investors

Grapefruit Health provides healthcare organizations with a workforce of trained clinical students—recruited from pre-med, nursing, pharmacy, social work, and similar programs—who are integrated into care team workflows to close care gaps and address staffing shortages. It handles recruiting, vetting, training, and quality assurance for these students, who serve as "Patient Champions" for healthcare provider clients in the US.

7 investors

Groups provides medication-assisted treatment for opioid and substance use disorder, offering Suboxone treatment through in-person and virtual programs that accept insurance and Medicaid.

7 investors

Handl Health is an AI platform that aggregates and analyzes publicly available healthcare price transparency data to help insurance brokers and benefits consultants build and maintain affordable health plans for their clients. It serves the US employee benefits market by turning pricing data into a self-service tool for winning new business, retaining clients, and finding cost savings.

7 investors

Handspring provides virtual mental health therapy for children, teens, and young adults, with insurance coverage and rapid access to care without waitlists. The company aims to address the gap in affordable, evidence-based behavioral health services for families struggling to access quality care.

7 investors

Harbor Health is a healthcare provider and insurance company operating clinics across Texas that offers primary care, specialty care, and health coaching alongside integrated insurance coverage.

7 investors

Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases. The company serves patients, families, and advocates in the rare disease community through novel drug development and patient-centered approaches.

7 investors

Health In Her Hue is a digital platform connecting Black women and women of color with culturally responsive healthcare providers, health content, and peer support communities. It offers provider search, a curated library of medical articles and personal stories, and Care Squad peer support groups organized around specific health topics.

7 investors

Healthie provides a software platform for healthcare practitioners including dietitians and life coaches to manage their practices and deliver virtual, recurring care to patients outside traditional hospital settings.

7 investors

Heartseed develops cardiac regenerative medicine, creating heart muscle cells from iPS cells for transplantation to treat heart failure, with its lead pipeline HS-001 nearing clinical trials. The company targets patients with heart failure caused by conditions such as myocardial infarction, with reference markets in Japan and the US.

7 investors

Helaina uses precision fermentation to produce human proteins, including lactoferrin and other bioactive nutrients found in human milk, for consumer nutrition products serving athletes, new parents, and health-conscious consumers.

7 investors

Homage connects seniors in Singapore with trained, vetted local caregivers who provide in-home care services. The platform enables families to book, manage, and pay for caregiver visits through a mobile app.

7 investors

LexisNexis Health Intelligence (formerly Human API Health Intelligence) provides electronic health record (EHR) data access and integration for life insurance carriers and underwriters. Its platform connects to over 30,000 U.S. health data sources to deliver unified health data and medical insights that speed up underwriting decisions.

7 investors

Hyivy Health develops a holistic pelvic health device that treats, monitors, tracks, and helps prevent pelvic floor symptoms, along with connecting patients to clinicians and pelvic floor therapists. The company focuses on women's health and pelvic floor rehabilitation.

7 investors

ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company developing immune therapies for immune-excluded tumors, which resist standard PD-1 blockade. Its lead candidate, IMGS-001, is a cytotoxic immune checkpoint inhibitor aimed at cancers such as colorectal, ovarian, and non–small cell lung cancer.

7 investors

iMicrobes uses synthetic biology to develop cost-effective sustainable materials and replace conventional manufacturing processes. The company focuses on circular economy principles, converting waste streams into value through biotechnology.

7 investors

Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants. The company operates in the infant health and microbiome therapeutics space.

7 investors